Whole grains: a meta-analysis finds modest cardiometabolic benefits

Do whole grains improve cardiovascular risk factors beyond the associations observed in dietary studies? A meta-analysis of 87 randomized trials reports several favorable effects, but their magnitude is small. The available abstract does not establish a reduction in heart attacks or an optimal amount to consume.

Various whole grains presented in bowls.
NutritionEditorial illustration, not study data.

A review focused on risk factors

The researchers pooled 87 randomized trials, described in 101 publications, to examine the effects of whole grains on various cardiometabolic measures. Their analyses express mean differences per 48 g per day increase in whole grains, measured by dry weight.

This unit is used to compare trial results: it is not an individual prescription. The abstract provided does not specify the total number of participants, the duration of the interventions, or the detailed characteristics of the participants and comparison foods.

Measurable but small differences

For this increase in consumption, the mean difference in weight was −0.20 kg, with a 95% confidence interval ranging from −0.31 to −0.09 kg. Waist circumference decreased by an average of 0.22 cm and total cholesterol by 0.10 mmol/L. The authors rate the certainty of these findings as high.

LDL cholesterol decreased by an average of 0.07 mmol/L and systolic blood pressure by 0.82 mmHg. The authors rate the certainty as moderate for these two findings, as well as for the small reductions in triglycerides and fasting blood glucose.

These figures describe averages between groups, not what each person can expect. They concern risk factors: this analysis does not directly demonstrate a reduction in cardiovascular events.

No established optimal amount

Nonlinear analyses suggest that the largest effects generally occur between 60 and 100 g per day. But the results vary depending on the measure, and data become sparse at higher intakes.

It would therefore be an overreach to turn this range into a universal target. Without the trial details, it is also impossible to specify how much the results depend on the type of grain, the baseline diet or the food being replaced.

Limitations to keep in mind

Only the PubMed abstract was consulted, not the full text. The populations, comparators, durations, heterogeneity and risks of bias cannot be examined in detail from the dossier. Funding and conflicts of interest have not been verified. Data on high intakes are limited.

What we can take away

Takeaway: the trials support a favorable but modest effect of whole grains on several cardiometabolic risk factors. They justify neither a promise of substantial weight loss nor an optimal amount that applies to everyone.

Sources and provenance

Partager cet article

X f in

An error or a source to report? Contact the editorial team.